Data / Drug companies / Amlodipine besylate and benazepril hydrochloride
Amlodipine besylate and benazepril hydrochloride: 12 companies and 52 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Amlodipine besylate and benazepril hydrochloride is listed in the FDA National Drug Code Directory by 12 companies, with 52 products in commercial distribution. 52 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule, and the newest product started marketing on October 29, 2026.
The request: Get every company that lists amlodipine besylate and benazepril hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 12
- Products
- 52
- Generic (ANDA) products
- 52 (100.0%)
- Application numbers
- 4
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list amlodipine besylate and benazepril hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Lupin Pharmaceuticals, Inc. | 10 | capsule | Generic drugs (ANDA) | October 4, 2018 |
| A-S Medication Solutions | 6 | capsule | Generic drugs (ANDA) | October 4, 2018 |
| BluePoint Laboratories | 6 | capsule | Generic drugs (ANDA) | July 16, 2015 |
| Bryant Ranch Prepack | 6 | capsule | Generic drugs (ANDA) | October 4, 2018 |
| Dr. Reddy's Laboratories Limited | 6 | capsule | Generic drugs (ANDA) | July 5, 2011 |
| Remedyrepack Inc. | 5 | capsule | Generic drugs (ANDA) | October 11, 2025 |
| Amneal Pharmaceuticals NY LLC | 4 | capsule | Generic drugs (ANDA) | April 14, 2026 |
| AvKARE | 4 | capsule | Generic drugs (ANDA) | October 29, 2026 |
| PD-Rx Pharmaceuticals, Inc. | 2 | capsule | Generic drugs (ANDA) | August 1, 2018 |
| Northwind Health Company, LLC | 1 | capsule | Generic drugs (ANDA) | April 19, 2023 |
| Northwind Health Company, LLC | 1 | capsule | Generic drugs (ANDA) | January 19, 2024 |
| Preferred Pharmaceuticals Inc. | 1 | capsule | Generic drugs (ANDA) | January 15, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 52 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 52 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Angiotensin Converting Enzyme Inhibitor | 52 |
| Calcium Channel Blocker | 52 |
| Dihydropyridine Calcium Channel Blocker | 52 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.